Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

We recently published a list of 10 Firms Hit Hard in Thursday’s Trading. In this article, we are going to take a look at ...

Medical technology company Hologic (NASDAQ:HOLX) in Q4 CY2024, but sales were flat year on year at $1.02 billion. On the ...

Hologic Inc. closed 22.70% short of its 52-week high of $84.67, which the company reached on August 9th.

Hologic lowered its fiscal 2025 revenue forecast, citing weakness in sales of its breast health products, sending the company's shares down 5% after the bell on Wednesday.

Hologic, Inc. (NASDAQ:HOLX – Get Free Report)’s stock price hit a new 52-week low during mid-day trading on Thursday after Leerink Partnrs downgraded the stock from a strong-buy rating to a hold ...

Hologic has officially announced the End-of-Sale and End-of-Life for the Hologic Fluoroscan InSight FD Mini C-Arm, with sales discontinuing on September 30, 2025. While Hologic has stated they will ...

The agreement with Tencent is the latest in a series of deals with media partners and sponsors secured by WTA Ventures as part of its strategy to accelerate commercial growth and drive investment in ...

Hologic Inc (HOLX) reports a 1% revenue increase with robust diagnostics performance, while facing headwinds in breast health and skeletal revenue. The headline numbers for Hologic (HOLX ...